- Home
- EXEL vs FLS Comparison
EXEL vs FLS Comparison
Compare EXEL & FLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- FLS
- Stock Information
- Founded
- EXEL 1994
- FLS 1790
- Country
- EXEL United States
- FLS United States
- Employees
- EXEL N/A
- FLS N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- FLS Fluid Controls
- Sector
- EXEL Health Care
- FLS Industrials
- Exchange
- EXEL Nasdaq
- FLS Nasdaq
- Market Cap
- EXEL 9.8B
- FLS 8.3B
- IPO Year
- EXEL 2000
- FLS N/A
- Fundamental
- Price
- EXEL $43.04
- FLS $49.92
- Analyst Decision
- EXEL Buy
- FLS Strong Buy
- Analyst Count
- EXEL 18
- FLS 9
- Target Price
- EXEL $38.76
- FLS $64.11
- AVG Volume (30 Days)
- EXEL 3.9M
- FLS 1.3M
- Earning Date
- EXEL 05-13-2025
- FLS 07-28-2025
- Dividend Yield
- EXEL N/A
- FLS 1.68%
- EPS Growth
- EXEL 237.58
- FLS 20.22
- EPS
- EXEL 2.20
- FLS 2.14
- Revenue
- EXEL $2,298,922,000.00
- FLS $4,614,870,000.00
- Revenue This Year
- EXEL $10.39
- FLS $7.11
- Revenue Next Year
- EXEL $10.74
- FLS $3.67
- P/E Ratio
- EXEL $19.53
- FLS $23.32
- Revenue Growth
- EXEL 24.49
- FLS 4.23
- 52 Week Low
- EXEL $20.40
- FLS $37.34
- 52 Week High
- EXEL $48.85
- FLS $65.08
- Technical
- Relative Strength Index (RSI)
- EXEL 59.93
- FLS 55.04
- Support Level
- EXEL $42.21
- FLS $48.24
- Resistance Level
- EXEL $43.75
- FLS $51.25
- Average True Range (ATR)
- EXEL 1.60
- FLS 1.10
- MACD
- EXEL -0.09
- FLS -0.09
- Stochastic Oscillator
- EXEL 53.96
- FLS 39.44
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About FLS Flowserve Corporation
Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. In addition, Flowserve has a network of Quick Response Centers to provide aftermarket equipment services. The aftermarket services help customers with installation, diagnostics, repair, and retrofitting. Sales are roughly split across many regions, with North America and Europe contributing the majority of total revenue.